LMZ(SH:600249) Xin Lang Cai Jing·2025-10-28 11:50Core Viewpoint - The company, Two Sides Needle, is a well-known domestic oral care brand with a focus on oral care products and personal hygiene items, facing challenges in revenue and profit compared to industry leaders [1][2]. Group 1: Business Performance - In Q3 2025, Two Sides Needle reported revenue of 815 million, ranking 4th in the industry, with the top competitor, Runben Co., achieving 1.238 billion [2]. - The main business composition includes daily chemical products at 458 million (87.71%), pharmaceuticals at 51.17 million (9.80%), and other categories at 6.94 million (1.33%) [2]. - The net profit for the same period was 24.6 million, also ranking 4th, with the industry leader's net profit at 266 million [2]. Group 2: Financial Ratios - The company's debt-to-asset ratio stood at 20.88% in Q3 2025, lower than the industry average of 25.71% [3]. - The gross profit margin was reported at 16.58%, which is below the industry average of 37.91% [3]. Group 3: Executive Compensation - The total compensation for the president, Gong Huiquan, was 388,000, reflecting an increase of 45,100 from the previous year [4]. Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 8.03% to 47,000, while the average number of shares held per shareholder increased by 8.73% to 11,700 [5].